Membership & Benefits
Exclusive Networking & Social Events
Exclusive quarterly events such as CEO presentations, educational opportunities and social gatherings where focus is on deep-dives & analysis of biopharma deals and cutting-edge innovation
Nordic Pharma Licensing Networking
NPLG brings together the most relevant network of licensing professionals in the Northern European pharma & biotech industry
Premier Courses across Europe and Scandinavia
Opportunities to participate in high quality business development, licensing and fundraising courses offered by EPLG affiliates across Europe and in Scandinavia
European & International Pharma Licensing Group Access
What's The Big Deal?
NPLG introduces a fresh new concept - a deep dive into deal making far beyond what the headlines or press releases reveal
Quarterly meetings will feature a break down and examination by the CEO or deal maker into an intriguing deal, deal process, IPO or fundraising event, including the story behind the deal and the key lessons learned
What's The Big Deal?
A Nordic Biotech Success Story -
Forendo Pharma’s Journey to Acquisition
Date: February 27, 2025
Time: 16:45
Venue: Gorrissen Federspiel, Axel Towers, Copenhagen
RSVP: For NPLG members only. For membership email us at info@nplg.eu
Our Ambition: Art of the Deal, Learning & Innovation
The Nordic Pharma Licensing Group (NPLG) is an exclusive networking and deal excellence platform open to current and aspiring leaders involved in partnering transactions, fundraising, licensing & business development. Our members are motivated to inspire and be inspired by innovative contemporaries in the pharmaceutical ecosystem.
The yearly membership fee is 175 € and includes many benefits.
Our Events! What's the Big Deal? & other Networking Events
A Nordic Biotech Success Story - Forendo Pharma’s Journey to Acquisition
Maarit Merla, CEO Finnish Drug Discovery Center, Previously CBO Forendo Pharma and
Stephan Christgau, Founding Partner at Eir Ventures Previously Investor in
Forendo Pharma
Date: February 27, 2024
Time: 16:45
Venue: Gorrissen Federspiel, Axel Towers, Copenhagen
Dinner: 19:15-21:00 Madklubben, Vesterbro
RSVP: For NPLG members only.
NPLG Annual General Meeting 2025
Date: February 27, 2024
Time: 16:15-16:45
Venue: Gorrissen Federspiel, Axel Towers, Copenhagen
2025 AGM Agenda:
-
Summary of 2024
-
Nominations/volunteers and confirmations for 2025 NPLG Board and Chairpersons
-
All members are welcome to volunteer for the board or vote for nominees
-
-
Goals for 2025
-
Frequency of board meetings, number of events, new members, types of memberships, sponsorships, subject matter
-
-
AOB
-
Closing of AGM
NPLG Presents What's the Big Deal? Spring Meeting
Presenters: TBD
Date: TBD
Time slot: TBD
Venue: TBD
Associate
Sound Bioventures
NPLG Co-Chair
Philip is a seasoned physician-scientist (cardiology) with end-to-end experience in life-science venture capital investments. He is eager to spar with deal makers, connect all stakeholders around the deal table, drive novel insights and be at the forefront of biotech deal making innovation. Philip holds board positions in several companies/organizations.
Philip joined NPLG as Co-Chair in 2024.
Philip Brainin
Founder and Principal
Heitner Biopharm Consultation
NPLG Co-Chair
Tara is an entrepreneurial business developer with a scientific background. She founded Heitner Biopharm Consultation in 2014 and has since supported over 14 biotech and pharma companies in deal making, strategy and commerical assessment. She enjoys the community learning and professional development as well as the chance to meet inspirational deal makers and entrepreneurs.
Tara joined NPLG and the Board in 2017.
Tara Heitner
Chief Executive Officer
Kurantis
NPLG Board Member
Tanja is an entrepreneur who beside running Kurantis, a Nordic pharmaceutical distribution company, is the owner of Makantia, a BD and licensing consultancy. She is also a partner in Solanum selling natural care and supplements for animals. Her passion as a board member is to empower innovation, networking and collaboration within the Nordic pharma and biotech ecosystem.
Tanja joined NPLG in 2016 and the Board in 2024.
Tanja Breum Nielsen
.png)
The NPLG Board
Partner
Gorrissen Federspiel
NPLG Board Member
Martin co-heads Gorrissen Federspiel's top Life Sciences Practice Group, which provides leading advice to innovative international and national Life Sciences companies, including advisory and litigation support within regulatory, market access, transactions, capital markets/PE and product liability. Martin has decades of experience assisting Life Sciences companies at every step of the product life cycle. He is an internationally recognized expert within Regulatory Life Science, Product Liability and IP/Trade Secrets Litigation.
Martin has been on the NPLG Board since 2018.
Martin Dræbye Gantzhorn
Senior Principal
Angelini Ventures
NPLG Board Member
Thomas comes with extensive experience in venture capital and business development. Angelini Industries invests in life science, therapeutic medtech and digital health globally. Previously, Thomas worked for Lundbeck A/S as a Director for Corporate Business Development & Strategy, for UCB Pharma, as Associate Director for Global Business Development and at Sunstone Life Science Ventures, a Danish Venture Capital fund. Thomas currently holds Board positions in several biotech and life science companies in North America.
Thomas joined the NPLG Board in 2024.
Thomas Thestrup
Founder
MBIO Consulting
NPLG Board Member
Mads has extensive experience as a drug hunter with a passion for life science business, innovation and strategy. He has held several R&D leadership and BD positions in pharma and biotech. Currently, he works with universities and startups in the life science space with a special focus on novel therapeutics. He is committed to help create an inspiring meeting place for like-minded professionals that are part of the vibrant northern european biotech and pharma ecosystem.
Mads joined the NPLG Board in 2024
Mads Aaboe Jensen
Mission
To empower pharmaceutical deal makers by providing a platform for knowledge exchange, networking, and professional development, through exclusive social events with prominent keynote speakers and roundtable discussions of recent transactions
Vision
To be the leading network for healthcare deal makers in the Northern European region, fostering knowledge-sharing and collaboration to fuel the future of healthcare
Member Profile
NPLG aims to include professionals involved in transactions and deal making. Contact us using the form below for more information about membership.
Resources
PLG Business Development Training
Introduction to Healthcare Business Development
The course is on March 5-7, 2025 in London.
Click here for Group training link.
Please visit Life Sciences Academy by Osborne Clarke for high quality webinars to help you to navigate legal and compliance challenges in the Life Sciences and Healthcare industry.
IPLS Members - Global list
Click here to view pdf
IPLS ICP Briefing Flyer Draft.pdf
Please follow this page and you can see all the various activity of the IPLS.